DiscoverMarkets & Money Today | 2 Min News | The Daily News Now!Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com
Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com

Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com

Update: 2025-10-31
Share

Description

Corbus Pharmaceuticals' stock plummets 22% after announcing a $75M public stock offering, diluting existing investors' stakes. The company aims to fund drug pipeline development and general expenses, with Jefferies, RBC Capital Markets, LifeSci Capital, and Mizuho Securities as lead managers. The market's concern over risks outweighing rewards leads to a sharp sell-off.

The Daily News Now! — Every city. Every story. AI-powered.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com

Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com